194 related articles for article (PubMed ID: 26171666)
1. The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.
Godar SC; Mosher LJ; Strathman HJ; Gochi AM; Jones CM; Fowler SC; Bortolato M
Br J Pharmacol; 2016 Jul; 173(13):2111-21. PubMed ID: 26171666
[TBL] [Abstract][Full Text] [Related]
2. Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome.
Fowler SC; Mosher LJ; Godar SC; Bortolato M
J Neurosci Methods; 2017 Dec; 292():37-44. PubMed ID: 28099872
[TBL] [Abstract][Full Text] [Related]
3. Isoallopregnanolone reduces tic-like behaviours in the D1CT-7 mouse model of Tourette syndrome.
Cadeddu R; Bäckström T; Floris G; Nordkild P; Segerdahl M; Bortolato M
J Neuroendocrinol; 2020 Jan; 32(1):e12754. PubMed ID: 31175669
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models.
Mosher LJ; Godar SC; Nelson M; Fowler SC; Pinna G; Bortolato M
Sci Rep; 2017 Jun; 7(1):3348. PubMed ID: 28611376
[TBL] [Abstract][Full Text] [Related]
5. Behavioral fragmentation in the D1CT-7 mouse model of Tourette's syndrome.
Santangelo A; Bortolato M; Mosher LJ; Crescimanno G; Di Giovanni G; Cassioli E; Ricca V; Casarrubea M
CNS Neurosci Ther; 2018 Aug; 24(8):703-711. PubMed ID: 29314714
[TBL] [Abstract][Full Text] [Related]
6. Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.
Mosher LJ; Frau R; Pardu A; Pes R; Devoto P; Bortolato M
Br J Pharmacol; 2016 Jul; 173(13):2122-34. PubMed ID: 26101934
[TBL] [Abstract][Full Text] [Related]
7. The α6 GABA
Cadeddu R; Knutson DE; Mosher LJ; Loizou S; Odeh K; Fisher JL; Cook JM; Bortolato M
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33525455
[TBL] [Abstract][Full Text] [Related]
8. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.
Swerdlow NR
Neurosci Biobehav Rev; 2013 Jul; 37(6):1150-6. PubMed ID: 23017868
[TBL] [Abstract][Full Text] [Related]
9. Tics: neurological disorders determined by a deficit in sensorimotor gating processes.
Schilke ED; Tremolizzo L; Appollonio I; Ferrarese C
Neurol Sci; 2022 Oct; 43(10):5839-5850. PubMed ID: 35781754
[TBL] [Abstract][Full Text] [Related]
10. "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome.
Nordstrom EJ; Bittner KC; McGrath MJ; Parks CR; Burton FH
Brain Res; 2015 Dec; 1629():38-53. PubMed ID: 26453289
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of striatal desensitization in cortical-limbic hyperglutamatergic TS- & OCD-like transgenic mice.
O'Brien KB; Sharrief AZ; Nordstrom EJ; Travanty AJ; Huynh M; Romero MP; Bittner KC; Bowser MT; Burton FH
J Chem Neuroanat; 2018 Apr; 89():11-20. PubMed ID: 29481900
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiology.
Cadeddu R; Van Zandt M; Santovito LS; Odeh K; Anderson CJ; Flanagan D; Nordkild P; Pinna G; Pittenger C; Bortolato M
Neuropsychopharmacology; 2023 Aug; 48(9):1288-1299. PubMed ID: 37198434
[TBL] [Abstract][Full Text] [Related]
13. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction.
Campbell KM; Veldman MB; McGrath MJ; Burton FH
Neuroreport; 2000 Jul; 11(10):2335-8. PubMed ID: 10923696
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.
McGrath MJ; Campbell KM; Parks CR; Burton FH
Brain Res; 2000 Sep; 877(1):23-30. PubMed ID: 10980239
[TBL] [Abstract][Full Text] [Related]
15. Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings.
Zebardast N; Crowley MJ; Bloch MH; Mayes LC; Wyk BV; Leckman JF; Pelphrey KA; Swain JE
Psychiatry Res; 2013 Oct; 214(1):33-41. PubMed ID: 23916249
[TBL] [Abstract][Full Text] [Related]
16. Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming.
Xu M; Li L; Pittenger C
Neuroscience; 2016 Jun; 324():321-9. PubMed ID: 26968763
[TBL] [Abstract][Full Text] [Related]
17. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
Nordstrom EJ; Burton FH
Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
[TBL] [Abstract][Full Text] [Related]
18. Preclinical models relevant to Tourette syndrome.
Swerdlow NR; Sutherland AN
Adv Neurol; 2006; 99():69-88. PubMed ID: 16536353
[TBL] [Abstract][Full Text] [Related]
19. Neural correlates of altered sensorimotor gating in boys with Tourette Syndrome: A combined EMG/fMRI study.
Buse J; Beste C; Herrmann E; Roessner V
World J Biol Psychiatry; 2016 Apr; 17(3):187-97. PubMed ID: 26624257
[TBL] [Abstract][Full Text] [Related]
20. Updating neuropathology and neuropharmacology of monoaminergic systems.
Ramsay RR; De Deurwaerdère P; Di Giovanni G
Br J Pharmacol; 2016 Jul; 173(13):2065-8. PubMed ID: 27302283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
